Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy

Authors

  • Fábio Bucaretchi UNICAMP; Faculdade de Ciências Médicas e Hospital das Clínicas; Centro de Controle de Intoxicações
  • Danielly C. Vicente UNICAMP; Faculdade de Ciências Médicas; Departamento de Pediatria
  • Ricardo M. Pereira UNICAMP; Faculdade de Ciências Médicas; Departamento de Pediatria
  • Antonia T. Tresoldi UNICAMP; Faculdade de Ciências Médicas; Departamento de Pediatria

Keywords:

Dapsone syndrome, Sulfone syndrome, Hepatic failure, Leprosy

Abstract

A 12 y old girl was admitted 24 days after start a WHO multidrug therapy scheme for multibacillary leprosy (dapsone, clofazimine and rifampicin) with intense jaundice, generalized lymphadenopathy, hepatoesplenomegaly, oral erosions, conjunctivitis, morbiliform rash and edema of face, ankles and hands. The main laboratory data on admission included: hemoglobin, 8.4 g/dL; WBC, 15,710 cells/mm³; platelet count, 100,000 cells/mm³; INR = 1.49; increased serum levels of aspartate and alanine aminotransferases, gamma-glutamyl transpeptidase, alkaline phosphatase, direct and indirect bilirubin. Following, the clinical conditions had deteriorated, developing exfoliative dermatitis, shock, generalized edema, acute renal and hepatic failure, pancytopenia, intestinal bleeding, pneumonia, urinary tract infection and bacteremia, needing adrenergic drugs, replacement of fluids and blood product components, and antibiotics. Ten days after admission she started to improve, and was discharged to home at day 39th, after start new supervised treatment for leprosy with clofazimine and rifampicin, without adverse effects. This presentation fulfils the criteria for the diagnosis of dapsone hypersensitivity syndrome (fever, generalized lymphadenopathy, exfoliative rash, anemia and liver involvement with mixed hepatocellular and cholestatic features). Physicians, mainly in geographical areas with high prevalence rates of leprosy, should be aware to this severe, and probably not so rare, hypersensitivity reaction to dapsone.

Downloads

Download data is not yet available.

Downloads

Published

2004-12-04

Issue

Section

Case Report

How to Cite

Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy . (2004). Revista Do Instituto De Medicina Tropical De São Paulo, 46(6), 331-334. https://www.revistas.usp.br/rimtsp/article/view/30858